Table 1:
Patient demographics including age, sex, type of device, device characteristics, comorbidities, and cardiac history. TV: transvenous; S: subcutaneous.
| Age (years) | 60.9 ± 15.4 | |
| Male | 38 (70%) | |
| Female | 16 (30%) | |
| CIED | TV-ICD S-ICD | 33 (61%) 4 (7%) |
| Pacemaker | 15 (28%) | |
| CRT | 2 (4%) | |
| Pacer Dependent | 22 (41%) | |
| Manufacturer | Medtronic | 26 (48%) |
| Boston Scientific | 17 (32%) | |
| St. Jude Medical | 9 (17%) | |
| Biotronik | 2 (4%) | |
| Left Chest | 48 (89%) | |
| Right Chest | 2 (4%) | |
| Below Left Axilla | 4 (7%) | |
| Lead Location | Right Ventricle | 14 (28%) |
| Right Atrium, Right Ventricle | 24 (48%) | |
| Right Atrium, Right Ventricle, Left Ventricle | 12 (24%) | |
| Retained Lead | 2 (4%) | |
| Comorbidities | Coronary Artery Disease | 31 (57%) |
| Hypertension | 30 (56%) | |
| Hyperlipidemia | 29 (54%) | |
| Congestive Heart Failure | 27 (50%) | |
| Renal disease | 19 (35%) | |
| Obstructive Sleep Apnea | 19 (35%) | |
| Diabetes | 16 (30%) | |
| Chronic Obstructive Pulmonary Disease | 7 (13%) | |
| Cerebrovascular disease | 6 (11%) | |
| Cardiac History | Cardiac Arrhythmia | 51 (94%) |
| Prior ablation | 21 (39%) | |
| Ischemic Cardiomyopathy | 13 (24%) | |
| Non-ischemic Cardiomyopathy | 7 (13%) | |
| Dilated Cardiomyopathy | 5 (9%) | |
| Hypertrophic Cardiomyopathy | 4 (7%) | |
| Restrictive Cardiomyopathy | 1 (2%) | |
| Primary Prevention | 19 (51%) | |
| Secondary Prevention | 18 (49%) | |